The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Attention Score in Context
| Title |
P3-010 関節リウマチ患者におけるサラゾスルファピリジンのニューモシスチス肺炎発症抑制効果についての臨床的検討
|
|---|---|
| Published in |
Japanese Journal of Clinical Immunology, January 2015
|
| DOI | 10.2177/jsci.38.328b |
| Pubmed ID |
X Demographics
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 1 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 1 | 100% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 27 November 2021.
All research outputs
#17,636,985
of 25,850,671 outputs
Outputs from Japanese Journal of Clinical Immunology
#1
of 1 outputs
Outputs of similar age
#223,172
of 362,097 outputs
Outputs of similar age from Japanese Journal of Clinical Immunology
#1
of 3 outputs
Altmetric has tracked 25,850,671 research outputs across all sources so far. This one is in the 21st percentile – i.e., 21% of other outputs scored the same or lower than it.
So far Altmetric has tracked 1 research outputs from this source. They receive a mean Attention Score of 1.0. This one scored the same or higher as 0 of them.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 362,097 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 29th percentile – i.e., 29% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 3 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them